Daridorexant
QUVIVIQ is indicated for the treatment of adult patients with insomnia, characterized by difficulties with sleep onset and/or sleep maintenance [see Clinical Studies (14.1) ] .
United States
$489
per month
India
$188
per month
You save
−62%save $301/mo · 62% cheaper
46.3K US scripts/yr$13.9M potential annual savings$22.6M US spend/yr
Drag to rotate · 3D structureC23H23ClN6O2
SMILES: CC1=C(C=CC2=C1N=C(N2)[C@@]3(CCCN3C(=O)C4=C(C=CC(=C4)OC)N5N=CC=N5)C)Cl
Compare the price
US price$489per month
India price$188per month
You save$30162% less
Based on 30 units per month. US $16.30 vs India $6.27 per unit.
Total over 1 periodSave $301$489 → $188
The bigger picture
Daridorexant is filled about 46.3K times a year under Medicare Part D. At the prices above, that works out to roughly:
Est. annual US spend
$22.6M
If sourced from India
$8.7M
Potential annual savings
$13.9M
−62%
Rough estimate. Based on Medicare Part D prescription volume (not the entire US market) scaled by the representative monthly price — actual totals depend on dose, duration and coverage.